FindTrial
Sign In

Study on the effect of frailty on serum biological indicators, quality of life and survival of patients with radical prostatectomy.

Study on the effect of frailty on serum biological indicators, quality of life and survival of patients with radical prostatectomy.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072871
Enrollment
Unknown
Registered
2023-06-27
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Frailty:None
None-frailty:None

Sponsors

Anhui Provincial Hospital (The First Affiliated Hospital of University of Science and Technology of China)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Be diagnosed by relevant imaging examination or pathology; 2)Intended to do radical prostatectomy; 3) Agreed signing of informed consent.

Exclusion criteria

Exclusion criteria: 1) Suffering from other malignant tumors at the same time; 2) Patients with acute infection.

Design outcomes

Primary

MeasureTime frame
quality of life;serum biological indicators;—

Secondary

MeasureTime frame
Survival;—

Countries

China

Contacts

Public ContactWang Lei

Anhui Provincial Hospital (The First Affiliated Hospital of University of Science and Technology of China)

zhangjunchi819@163.com+86 180 1998 5789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026